What is PocDoc?
PocDoc operates a sophisticated digital platform designed to empower individuals to conduct self-testing for a variety of major diseases and conditions using a smartphone or tablet. The process involves a simple fingerprick, after which the PocDoc app provides a comprehensive health assessment, contextualizing the results and offering potential solutions. The platform is engineered to integrate with PocDoc's proprietary, in-house developed quantitative blood tests. While the current product line includes a Lipid Test, the company has ambitious plans to expand its rapid test offerings to cover diabetes, kidney and liver disease, and women's health, positioning itself as a key innovator in accessible diagnostics.
How much funding has PocDoc raised?
PocDoc has raised a total of $6.1M across 1 funding round:
Angel/Seed
$6.1M
Angel/Seed (2023): $6.1M with participation from Simplyhealth Group, MMC Ventures, and Forward Partners
Key Investors in PocDoc
Simplyhealth Group
Simplyhealth Group is a long-standing healthcare provider, established in 1872, focused on helping over 3 million people in the UK manage their everyday health needs through accessible products and services. Their investment in PocDoc aligns with their purpose of enabling better everyday health and their commitment to innovation in the health sector.
MMC Ventures
MMC Ventures Ltd is a London-based venture capital firm specializing in the Venture Capital & Private Equity industry. With a team of 20-49 employees and revenues between $5M-$10M, they are positioned to support companies like PocDoc in their growth and scaling phases.
Forward Partners
Forward Partners operates with a focused investment strategy, aiming to provide enhanced support to its portfolio companies. Their involvement suggests a strategic alignment with PocDoc's innovative approach to digital health diagnostics.
What's next for PocDoc?
The substantial enterprise-level backing and recent strategic investment signal a pivotal growth phase for PocDoc. This capital infusion is expected to accelerate the development and rollout of its planned diagnostic tests, further enhancing the platform's capabilities. The company's focus on integrating smartphone accessibility with rapid, in-house developed tests suggests a strategy aimed at disrupting traditional healthcare diagnostics by offering convenience and speed. PocDoc is poised to scale its operations, potentially expanding its market reach and solidifying its position as a leader in the digital health and at-home testing market.
See full PocDoc company page
